Trials / Recruiting
RecruitingNCT07007078
Efficacy of Dihydroartemisinin for Treating Acne Vulgaris
A Pilot Study to Evaluate the Therapeutic Effect of Dihydroartemisinin on Acne Vulgaris
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to learn if dihydroartemisinin (DHA) works to treat Acne Vulgaris in adults. The main question it aims to answer is: • Does DHA improve the acne severity by at least one grade after treatment. Researchers will treat patients who are clinically diagnosed as Acne Vulgaris to see if DHA works to alleviate the symptoms of Acne Vulgaris. Participants will: * Take DHA every day for 3 months * Visit the clinic once every month for checkups and tests
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dihydroartemisinin | DHA 40mg tid for 90 days |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2026-05-01
- Completion
- 2026-12-01
- First posted
- 2025-06-05
- Last updated
- 2025-06-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07007078. Inclusion in this directory is not an endorsement.